Cogent Biosciences, Inc. (COGT) stock analysis

In our weekly check, Cogent Biosciences, Inc. is graded D (A to F). Of 19 checks on debt, profit, cash flow and trend: 6 pass, warnings: 4, red flags: 9.

About Cogent Biosciences, Inc.

Cogent Biosciences, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as COGT.

What our checks show for COGT

Red flags

Warning signs

Strengths

Similar companies

EWTX · TVTX · IONS · DNTH · ADPT · SRRK

Questions

What grade does Cogent Biosciences, Inc. (COGT) have?

In our weekly check, Cogent Biosciences, Inc. is graded D (A to F). Of 19 checks on debt, profit, cash flow and trend: 6 pass, warnings: 4, red flags: 9. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of COGT stock?

This week's biggest flags for Cogent Biosciences, Inc.: High debt, Weak interest cover, Weak EPS growth. In total 13 of 19 checks show a warning or a red flag.

What does Cogent Biosciences, Inc. do?

Cogent Biosciences, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as COGT.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis